Octave Presents Data from Nine Company and Partner Abstracts at ACTRIMS Forum 2023
Real-world data sets show components of value-based care, use of Octave’s Multiple Sclerosis Disease Activity test and deep scan biomarker screening capabilities to evaluate evidence of disability, disease activity, and disease progression Study pres...